Halimah Hana A Kari, Saharuddin Ahmad
MBChB, Department of Family Medicine, Hospital Canselor Tuanku Muhriz UKM, Jalan Yaacob Latif, Bandar Tun Razak, Kuala Lumpur, Malaysia.
MD, MMed (FamMed), Department of Family Medicine, Hospital Canselor Tuanku Muhriz UKM, Jalan Yaacob Latif, Bandar Tun Razak, Kuala Lumpur, Malaysia. E-mail:
Malays Fam Physician. 2025 May 10;20:28. doi: 10.51866/cr.734. eCollection 2025.
Herein, we present the case of a 45-year-old woman with a history of Graves' disease who underwent radioactive iodine therapy and was prescribed different oral preparations of thyroxine. Despite initial tolerance to the medication, she developed hypersensitivity reactions 3 months after consumption, which presented as urticarial rashes, erythematous maculopapular eruptions and angio-oedema. She tried a different preparation of thyroxine accompanied by antihistamines but continued having persistent reactions. This led to her discontinuation of thyroxine, resulting in overt hypothyroidism with secondary dyslipidaemia and weight gain. A diagnosis of delayed thyroxine hypersensitivity was made based on history, clinical assessment and supportive evidence from the Naranjo Adverse Drug Reaction Probability Scale.
在此,我们报告一例45岁患有格雷夫斯病的女性病例,该患者接受了放射性碘治疗,并被开具了不同的口服甲状腺素制剂。尽管最初对药物耐受,但在服用3个月后她出现了过敏反应,表现为荨麻疹、红斑性斑丘疹和血管性水肿。她尝试了不同的甲状腺素制剂并同时服用抗组胺药,但仍持续出现反应。这导致她停用甲状腺素,进而发展为明显的甲状腺功能减退,并伴有继发性血脂异常和体重增加。根据病史、临床评估以及纳伦霍药物不良反应概率量表的支持性证据,诊断为迟发性甲状腺素过敏。